Healthcare Publications Smoking Cessation and Nicotine De-Addiction Market

Market Scenario:
Smoking cessation and nicotine de-addiction are drugs and therapies used in the treatment
of withdrawal symptoms associated with the cessation of nicotine. According to the World
Health Organization tobacco kills around 6 million people each year and of these almost 5
million deaths are the result of direct tobacco use and approximately 600,000 are the result
of passive smoking. Tobacco also derives its users of income, raises healthcare cost and
hinder economic development.
Nicotine use also is a risk factor for many diseases and disorders such as cardiovascular
diseases, cancer etc. Green tobacco sickness, caused by nicotine absorption through the
skin by the handling of wet tobacco leaves in tobacco industry is also a concern especially
among children. Tobacco quitting assistance in the form of national cessation services with
cost-coverage are available in only 24 countries, representing 15% of the world's
population. Only 42 countries, representing 19% of the world's population, have instituted
advertisement regulations such as pictorial warnings.
Get Premium Sample Copy @
https://www.marketresearchfuture.com/sample_request/2737
The other market driving factors include increasing desire and drives to quit smoking and
active role of social and health organizations against tobacco use, the prohibitive costs due
to high taxes leveraged on tobacco products, social stigma imposed on tobacco users etc.
The other critical market driving factor is the huge number of unmet needs. The World
Health Organization (WHO), estimates around 1,100 million smokers worldwide with
emerging economies accounting for around 70% of the global smoker population.
The market trends include development of better products such as nicotine gums and
patches, e-cigarette’s etc.
The market for Middle East and Africa smoking cessation and nicotine de-addiction was
estimated to be around $ 1040 million in 2016. Taking all factors into consideration, we
expect the Middle East and Africa smoking cessation and nicotine de-addiction market to
reach around $ 2108.38 million, by 2022 growing at a CAGR of 12.5%.
Key Players of Middle East and Africa Smoking Cessation and Nicotine De-
Addiction Market:
Some of the key players in this market are Pfizer Inc, VMR Products LLC, Johnson &
Johnson, Novartis International AG, Cipla Inc., and GlaxoSmithKline plc. Nicotek LLC., and
Lorillard, Inc. and others.
Segments:
Middle East and Africa smoking cessation and nicotine de-addiction products market has
been segmented on the basis of treatment which comprises of pharmacological, therapies
etc. On the basis of product type; market is segmented into drugs, inhalers, patches, sprays
and gums and others. On the basis of distribution channels; market is segmented into
pharmacies, online and de-addiction centers.
Regional Analysis of Middle East and Africa Smoking Cessation and Nicotine De-